DWA
CTSO icon

Dorsey Wright & Associates’s Cytosorbents Corp CTSO Stock Holding History

Dorsey Wright & Associates’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-913
Closed -$9K – 316
2020
Q2 		$9K Buy
+913
New +$8.38K ﹤0.01% 277
2018
Q4 		– Sell
-1,266
Closed -$16K – 286
2018
Q3 		$16K Buy
+1,266
New +$15.9K ﹤0.01% 199

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dorsey Wright & Associates's CTSO Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Cytosorbents Corp (CTSO) in Q3 2020, closing a stake of 913 shares — an estimated $9K sold.

Dorsey Wright & Associates first reported a position in CTSO in Q3 2018 and held it in 2 quarters. The position peaked at $16K in Q3 2018. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Cytosorbents Corp position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 913 Cytosorbents Corp shares in Q3 2020, an estimated $9K.
  • Dorsey Wright & Associates first reported a position in Cytosorbents Corp in Q3 2018 and held it in 2 quarters.
  • Dorsey Wright & Associates's Cytosorbents Corp position peaked at $16K in Q3 2018.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.